Meretek's UBT urea breath test 95% accurate in detection of H. pylori, study shows.
This article was originally published in The Gray Sheet
Executive Summary
MERETEK'S UBT UREA BREATH TEST 95% ACCURATE IN DETECTION OF H. PYLORI, according to a study by David Graham, MD, MACG, Baylor College of Medicine, Houston, et al., published in the April issue of the American Journal of Gastroenterology. The study concludes that the noninvasive Carbon-13 urea breath test "has the potential to be an important tool both in the diagnosis of infection and in patient management after antimicrobial therapy." A combination 510(k)/new drug application for the test kit, submitted in May 1995, is pending at FDA.
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.